Beryl Drugs Q1 Results
- BSE: 524606
- NSE: -
- ISIN: INE415H01017
- Sector: Biotechnology & Drugs
BSE
19.85
0.45 (2.32%)
0.45 (2.32%)Volume976.00
Updated: Mon 19 May, 2025 | 14:56:24
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Beryl Drugs Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 24 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 6.25 | 2.98 | 110.02% | 6.25 | N/A |
| Selling/ General/ Admin Expenses Total | 0.50 | 0.49 | 1.62% | 0.50 | N/A |
| Depreciation/ Amortization | 0.28 | 0.32 | -10.68% | 0.28 | N/A |
| Other Operating Expenses Total | 1.35 | -0.33 | 0.00% | 1.35 | N/A |
| Total Operating Expense | 5.58 | 3.50 | 59.65% | 5.58 | N/A |
| Operating Income | 0.67 | -0.52 | 0.00% | 0.67 | N/A |
| Net Income Before Taxes | 0.50 | -0.42 | 0.00% | 0.50 | N/A |
| Net Income | 0.37 | -0.35 | 0.00% | 0.37 | N/A |
| Diluted Normalized EPS | 0.73 | -0.68 | 0.00% | 0.73 | N/A |